193 related articles for article (PubMed ID: 18570904)
21. BZP-party pills: a review of research on benzylpiperazine as a recreational drug.
Cohen BM; Butler R
Int J Drug Policy; 2011 Mar; 22(2):95-101. PubMed ID: 21242080
[TBL] [Abstract][Full Text] [Related]
22. Subjective effects in humans following administration of party pill drugs BZP and TFMPP alone and in combination.
Lin JC; Jan RK; Kydd RR; Russell BR
Drug Test Anal; 2011 Sep; 3(9):582-5. PubMed ID: 21538945
[TBL] [Abstract][Full Text] [Related]
23. Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP.
Elliott S; Smith C
J Anal Toxicol; 2008 Mar; 32(2):172-7. PubMed ID: 18334102
[TBL] [Abstract][Full Text] [Related]
24. Party pills and drug-drug interactions.
Murphy M; Antia U; Chang HY; Han JY; Ibrahim U; Tingle M; Russell B
N Z Med J; 2009 Apr; 122(1293):3564. PubMed ID: 19448787
[TBL] [Abstract][Full Text] [Related]
25. Toxic effects of BZP-based herbal party pills in humans: a prospective study in Christchurch, New Zealand.
Gee P; Richardson S; Woltersdorf W; Moore G
N Z Med J; 2005 Dec; 118(1227):U1784. PubMed ID: 16372033
[TBL] [Abstract][Full Text] [Related]
26. Multiorgan failure from 1-benzylpiperazine ingestion--legal high or lethal high?
Gee P; Jerram T; Bowie D
Clin Toxicol (Phila); 2010 Mar; 48(3):230-3. PubMed ID: 20184432
[TBL] [Abstract][Full Text] [Related]
27. The impact of the prohibition of benzylpiperazine (BZP) 'legal highs' on the prevalence of BZP, new legal highs and other drug use in New Zealand.
Wilkins C; Sweetsur P
Drug Alcohol Depend; 2013 Jan; 127(1-3):72-80. PubMed ID: 22819869
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of 'party pill' drug N-benzylpiperazine (BZP) in healthy human participants.
Antia U; Lee HS; Kydd RR; Tingle MD; Russell BR
Forensic Sci Int; 2009 Apr; 186(1-3):63-7. PubMed ID: 19261399
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous determination of N-benzylpiperazine and 1-(3-trifluoromethylphenyl)piperazine in rat plasma by HPLC-fluorescence detection and its application to monitoring of these drugs.
Wada M; Yamahara K; Ikeda R; Kikura-Hanajiri R; Kuroda N; Nakashima K
Biomed Chromatogr; 2012 Jan; 26(1):21-5. PubMed ID: 21387353
[TBL] [Abstract][Full Text] [Related]
30. Acute effects of BZP, TFMPP and the combination of BZP and TFMPP in comparison to dexamphetamine on an auditory oddball task using electroencephalography: a single-dose study.
Lee H; Wang GY; Curley LE; Sollers JJ; Kydd RR; Kirk IJ; Russell BR
Psychopharmacology (Berl); 2016 Mar; 233(5):863-71. PubMed ID: 26630992
[TBL] [Abstract][Full Text] [Related]
31. Investigation of the effects of 'piperazine-containing party pills' and dexamphetamine on interhemispheric communication using electroencephalography.
Lee H; Wang GY; Curley LE; Kydd RR; Kirk IJ; Russell BR
Psychopharmacology (Berl); 2016 Aug; 233(15-16):2869-77. PubMed ID: 27289365
[TBL] [Abstract][Full Text] [Related]
32. Detection of 1-benzylpiperazine and 1-(3-trifluoromethylphenyl)-piperazine in urine analysis specimens using GC-MS and LC-ESI-MS.
Vorce SP; Holler JM; Levine B; Past MR
J Anal Toxicol; 2008; 32(6):444-50. PubMed ID: 18652752
[TBL] [Abstract][Full Text] [Related]
33. Piperazine compounds as drugs of abuse.
Arbo MD; Bastos ML; Carmo HF
Drug Alcohol Depend; 2012 May; 122(3):174-85. PubMed ID: 22071119
[TBL] [Abstract][Full Text] [Related]
34. Nephrotoxicity of recreational party drugs.
Berney-Meyer L; Putt T; Schollum J; Walker R
Nephrology (Carlton); 2012 Feb; 17(2):99-103. PubMed ID: 22066519
[TBL] [Abstract][Full Text] [Related]
35. Detection of 1-benzylpiperazine, 1-(3-trifluoromethylphenyl)-piperazine, and 1-(3-chlorophenyl)-piperazine in 3,4-methylenedioxymethamphetamine-positive urine samples.
Dickson AJ; Vorce SP; Holler JM; Lyons TP
J Anal Toxicol; 2010 Oct; 34(8):464-9. PubMed ID: 21819791
[TBL] [Abstract][Full Text] [Related]
36. Determining the subjective and physiological effects of BZP combined with TFMPP in human males.
Lin JC; Jan RK; Lee H; Jensen MA; Kydd RR; Russell BR
Psychopharmacology (Berl); 2011 Apr; 214(3):761-8. PubMed ID: 21060995
[TBL] [Abstract][Full Text] [Related]
37. Differential responses to anticipation of reward after an acute dose of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) alone and in combination using functional magnetic resonance imaging (fMRI).
Curley LE; Kydd RR; Kirk IJ; Russell BR
Psychopharmacology (Berl); 2013 Oct; 229(4):673-85. PubMed ID: 23666554
[TBL] [Abstract][Full Text] [Related]
38. Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market.
de Boer D; Bosman IJ; Hidvégi E; Manzoni C; Benkö AA; dos Reys LJ; Maes RA
Forensic Sci Int; 2001 Sep; 121(1-2):47-56. PubMed ID: 11516887
[TBL] [Abstract][Full Text] [Related]
39. MDMA-like behavioral effects of N-substituted piperazines in the mouse.
Yarosh HL; Katz EB; Coop A; Fantegrossi WE
Pharmacol Biochem Behav; 2007 Nov; 88(1):18-27. PubMed ID: 17651790
[TBL] [Abstract][Full Text] [Related]
40. Acute effects of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) using functional magnetic resonance imaging (fMRI) and the Stroop task--a pilot study.
Curley LE; Kydd RR; Robertson MC; Pillai A; McNair N; Lee H; Kirk IJ; Russell BR
Psychopharmacology (Berl); 2015 Aug; 232(16):2969-80. PubMed ID: 25893641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
